Back to search

Article

Multimodality treatment of malignant pleural mesothelioma

2018-10-22

Abstract excerpt

Malignant pleural mesothelioma (MPM) is a rare disease of the pleura and is largely related to asbestos exposure. Despite recent advancements in technologies and a greater understanding of the disease, the prognosis of MPM remains poor; the median overall survival rate is about 6 to 9 months in untreated patients. The main therapeutic strategies for MPM are surgery, chemotherapy, and radiation therapy (RT). The tw...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
74112e23-90b5-5cff-a18a-baab5e0ec822
DOI
10.12688/f1000research.15796.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multimodality treatment of malignant pleural mesotheliomaDOI 10.12688/f1000research.15796.1
Select a neighboring publication to make it the new centre.